- 1): 163–171, doi:10.1038/sj.bjp.0706406, PMC 1760722, PMID 16402100
Grotenhermen,
Franjo (2001). "FAQ: Why
should cannabis products be
heated before eating...
- 86–95. doi:10.3109/03602532.2013.849268. PMID 24160757. S2CID 29133059.
Grotenhermen F (2003). "Pharmacokinetics and
pharmacodynamics of cannabinoids". Clinical...
-
Archived from the
original (PDF) on 2014-05-13.
Retrieved 2014-03-14.
Grotenhermen F (2003). "Pharmacokinetics and
pharmacodynamics of cannabinoids". Clinical...
- 157–163. doi:10.1007/bf02003237. PMID 2178317. S2CID 23310488. Ujváry I,
Grotenhermen F (2014). "11-Nor-9-carboxy-Δ9-tetrahydrocannabinol – a
ubiquitous yet...
-
Archived from the
original on June 13, 2014.
Retrieved June 14, 2014.
Grotenhermen, F; Müller-Vahl, K (July 2012). "The
therapeutic potential of cannabis...
- org.
Archived from the
original on 2010-07-18.
Retrieved 2008-07-28.
Grotenhermen F (June 2001). "Harm
Reduction ****ociated with
Inhalation and Oral Administration...
- doi:10.1093/sleep/zsab149. ISSN 0161-8105. PMC 8598183. PMID 34115851.
Grotenhermen F, Müller-Vahl K (July 2012). "The
therapeutic potential of cannabis...
- "Expert
guide to a
legal Roadmap to Cannabis".
Retrieved 11
April 2024.
Grotenhermen, F. (2002). "The
Medical use of
Cannabis in Germany".
Journal of Drug...
- doi:10.1146/annurev-neuro-062111-150420. PMC 4273654. PMID 22524785.
Grotenhermen F (October 2005). "Cannabinoids".
Current Drug Targets. CNS and Neurological...
- 425–44. doi:10.1007/s00213-006-0508-y. PMID 17019571. S2CID 10328820.
Grotenhermen F (2003). "Pharmacokinetics and
pharmacodynamics of cannabinoids". Clinical...
